Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Cytotherapy|October 7, 2008
Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an updateR Seggewiss, D A Price, M A PurbhooThe Journal of Experimental Medicine|November 7, 2001
Sensory adaptation in naive peripheral CD4 T cellsK Smith, B Seddon, M A Purbhoo, et al.Journal of Molecular Medicine (Berlin, Germany)|October 10, 1998
The influence of antigenic variation on cytotoxic T lymphocyte responses in HIV-1 infectionD A Price, U C Meier, P Klenerman, et al.Proceedings of the National Academy of Sciences of the United States of America|May 16, 1998
Copresentation of natural HIV-1 agonist and antagonist ligands fails to induce the T cell receptor signaling cascadeM A Purbhoo, A K Sewell, P Klenerman, et al.Nature Medicine|April 15, 1999
Antagonism of cytotoxic T-lymphocyte activation by soluble CD8A K Sewell, U C Gerth, D A Price, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 8, 1999
Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependentJ A Whelan, P R Dunbar, D A Price, et al.The Journal of Biological Chemistry|July 5, 2001
The human CD8 coreceptor effects cytotoxic T cell activation and antigen sensitivity primarily by mediating complete phosphorylation of the T cell receptor zeta chainM A Purbhoo, J M Boulter, D A Price, et al.Gut|February 19, 2016
STAT4-associated natural killer cell tolerance following liver transplantationK M Jamil, T J Hydes, K S Cheent, et al.Immunity|May 24, 2001
A novel approach to antigen-specific deletion of CTL with minimal cellular activation using alpha3 domain mutants of MHC class I/peptide complexX N Xu, M A Purbhoo, N Chen, et al.Pageof 1